RxDoctor Payments Data

Brandi Hyde, APRN

Family · Paragould, ARNPI 1578243010

Payments from drug & device makers

$5,885in general payments, 2019–2025

Across 331 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$761
  • AbbVie$662
  • Neurocrine Biosciences, Inc.$505
  • Eisai Inc.$371
  • Amneal Pharmaceuticals LLC$369
  • CSL Behring$351
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$5,885100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,885 in reported general payments places this provider in the 90th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$39,072
Medicare patients
228
Services billed
496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa26$27,305
AptiomEslicarbazepine Acetate11$14,305
Ajovy AutoinjectorFremanezumab-Vfrm17$12,044
OngentysOpicapone16$10,224
Carbidopa-LevodopaCarbidopa/Levodopa78$1,856
Pregabalin59$1,758
Primidone116$1,708
Carbidopa-Levodopa ErCarbidopa/Levodopa38$1,263
Lacosamide15$1,149
Ropinirole Hcl72$984
Donepezil Hcl106$872
Memantine Hcl40$762
Levetiracetam16$743
Galantamine ErGalantamine Hbr15$678
AmantadineAmantadine Hcl13$541

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCRytary$369$27,30526 claims
Neurocrine Biosciences, Inc.Ongentys$505$10,22416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,103 family providers in Arkansas.

Other family in Paragould

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →